| 1 |
Alexander SE, Oelfke U, McNair HA, Tree AC. GI factors, potential to predict prostate motion during radiotherapy; a scoping review. Clin Transl Radiat Oncol 2023;40:100604. [PMID: 36936470 DOI: 10.1016/j.ctro.2023.100604] [Reference Citation Analysis]
|
| 2 |
Rokkas T, Hold GL. A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2023;35:471-9. [PMID: 36719820 DOI: 10.1097/MEG.0000000000002519] [Reference Citation Analysis]
|
| 3 |
Peros G, Gingert C. Chronische Obstipation – Definition, Diagnostik und Therapie. coloproctology. [DOI: 10.1007/s00053-022-00613-0] [Reference Citation Analysis]
|
| 4 |
Goodoory VC, Houghton LA, Black CJ, Ford AC. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterol Motil 2022;34:e14268. [PMID: 34532930 DOI: 10.1111/nmo.14268] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Elhusein AM, Fadlalmola HA. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis. Gastroenterol Nurs 2022;45:11-20. [PMID: 35108241 DOI: 10.1097/SGA.0000000000000652] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
Song KH. Functional Diarrhea. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_18] [Reference Citation Analysis]
|
| 7 |
Graff LA, Lackner JM. Gastrointestinal Disorders: Inflammatory Bowel Disease and Irritable Bowel Syndrome. Comprehensive Clinical Psychology 2022. [DOI: 10.1016/b978-0-12-818697-8.00118-7] [Reference Citation Analysis]
|
| 8 |
Heitmann PT, Vollebregt PF, Knowles CH, Lunniss PJ, Dinning PG, Scott SM. Understanding the physiology of human defaecation and disorders of continence and evacuation. Nat Rev Gastroenterol Hepatol 2021;18:751-69. [PMID: 34373626 DOI: 10.1038/s41575-021-00487-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 9 |
Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S, Aziz I. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterol Motil 2021;33:e14121. [PMID: 33719130 DOI: 10.1111/nmo.14121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Shapiro JM, Deutsch JK. Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:671-88. [PMID: 34304794 DOI: 10.1016/j.gtc.2021.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 45.0] [Reference Citation Analysis]
|
| 12 |
Barberio B, Judge C, Savarino EV, Ford AC. Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:638-48. [PMID: 34090581 DOI: 10.1016/S2468-1253(21)00111-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 13 |
Scott SM, Simrén M, Farmer AD, Dinning PG, Carrington EV, Benninga MA, Burgell RE, Dimidi E, Fikree A, Ford AC, Fox M, Hoad CL, Knowles CH, Krogh K, Nugent K, Remes-Troche JM, Whelan K, Corsetti M. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation. Neurogastroenterol Motil 2021;33:e14050. [PMID: 33263938 DOI: 10.1111/nmo.14050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Hou JJ, Wang X, Li Y, Su S, Wang YM, Wang BM. The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome. Microb Pathog 2021;157:104995. [PMID: 34048892 DOI: 10.1016/j.micpath.2021.104995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Hu Z, Li M, Yao L, Wang Y, Wang E, Yuan J, Wang F, Yang K, Bian Z, Zhong LLD. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterol 2021;21:23. [PMID: 33413140 DOI: 10.1186/s12876-020-01593-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 16 |
Barberio B, Judge C, Savarino EV, Ford A. Global Prevalence of Chronic Idiopathic Constipation According to the Rome Criteria: Systematic Review and Meta-Analysis. SSRN Journal. [DOI: 10.2139/ssrn.3800856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 17 |
Moore D, Young CJ. A systematic review and meta-analysis of biofeedback therapy for dyssynergic defaecation in adults. Tech Coloproctol 2020;24:909-18. [PMID: 32372153 DOI: 10.1007/s10151-020-02230-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Plasse TF, Barton G, Davidson E, Abramson D, Kalfus I, Fathi R, Raday G, Harris MS. Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial. Am J Gastroenterol 2020;115:1466-73. [PMID: 32639235 DOI: 10.14309/ajg.0000000000000727] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 19 |
Wong MYW, Hebbard G, Gibson PR, Burgell RE. Chronic constipation and abdominal pain: Independent or closely interrelated symptoms? J Gastroenterol Hepatol 2020;35:1294-301. [PMID: 31900961 DOI: 10.1111/jgh.14970] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Singh P, Lee HN, Rangan V, Ballou S, Lembo J, Katon J, McMahon C, Friedlander D, Iturrino J, Nee J, Lembo A. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol 2020;18:399-405.e1. [PMID: 31442602 DOI: 10.1016/j.cgh.2019.08.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 21 |
Chen H, Bair M, Chang W, Hsu C, Wong M, Hung J, Liu T, Yi C, Lei W, Chen C. Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes. Journal of the Formosan Medical Association 2020;119:75-80. [DOI: 10.1016/j.jfma.2019.02.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 22 |
Rahman MM, Ghoshal UC. Functional diarrhea. Clinical and Basic Neurogastroenterology and Motility 2020. [DOI: 10.1016/b978-0-12-813037-7.00034-0] [Reference Citation Analysis]
|
| 23 |
Shi Q, Tan L, Liu C, Wang H, Zhang J, Wang H, Zhai J. Comparative efficacy of pharmacological and nonpharmacological treatments for chronic idiopathic constipation in China: a Bayesian network meta-analysis. BMC Complement Altern Med 2019;19:311. [PMID: 31727037 DOI: 10.1186/s12906-019-2741-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Ferreira AI, Garrido M, Castro-Poças F. Irritable Bowel Syndrome: News from an Old Disorder. GE Port J Gastroenterol 2020;27:255-68. [PMID: 32775547 DOI: 10.1159/000503757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 25 |
Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2019;50:132-43. [PMID: 31157418 DOI: 10.1111/apt.15325] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 29.3] [Reference Citation Analysis]
|
| 26 |
Xu D, Chen VL, Steiner CA, Berinstein JA, Eswaran S, Waljee AK, Higgins PDR, Owyang C. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019;114:1043-50. [PMID: 30908299 DOI: 10.14309/ajg.0000000000000198] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 27 |
Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust 2018;209:86-91. [PMID: 29996755 DOI: 10.5694/mja18.00241] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 28 |
Aitella E, De Bartolomeis F, Savoia A, Fabiani M, Romano M, Astarita C. The overlap syndrome of urticaria and gastroesophageal reflux disease. PLoS One 2018;13:e0207602. [PMID: 30458030 DOI: 10.1371/journal.pone.0207602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Black CJ, Houghton LA, Ford AC. Insights into the evaluation and management of dyspepsia: recent developments and new guidelines. Therap Adv Gastroenterol 2018;11:1756284818805597. [PMID: 30397412 DOI: 10.1177/1756284818805597] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 30 |
Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 31 |
Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol 2018;113:1017-25. [PMID: 29880963 DOI: 10.1038/s41395-018-0074-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 32 |
Shah ED, Almario CV, Spiegel BMR, Chey WD. Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation. J Neurogastroenterol Motil 2018;24:299-306. [PMID: 29605985 DOI: 10.5056/jnm17112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 33 |
Kim SY, Choung RS, Lee SK, Choe JW, Jung SW, Hyun JJ, Koo JS, Lee SW, Shin C. Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil 2018;24:280-8. [PMID: 29605983 DOI: 10.5056/jnm17098] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 34 |
Dothel G, Barbaro MR, Raschi E, Barbara G, De Ponti F. Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert Opinion on Investigational Drugs 2018;27:251-263. [DOI: 10.1080/13543784.2018.1442434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. Am J Gastroenterol 2018;113:86-96. [PMID: 29134969 DOI: 10.1038/ajg.2017.421] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 19.6] [Reference Citation Analysis]
|
| 36 |
Patimah AW, Lee YY, Dariah MY. Frequency patterns of core constipation symptoms among the Asian adults: a systematic review. BMC Gastroenterol 2017;17:115. [PMID: 29096625 DOI: 10.1186/s12876-017-0672-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 37 |
Turner JM, Pattni SS, Appleby RN, Walters JR. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol 2017;8:279-83. [PMID: 29067154 DOI: 10.1136/flgastro-2017-100826] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 38 |
Black CJ, Ford AC. Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Aliment Pharmacol Ther 2017;46:697. [PMID: 28880445 DOI: 10.1111/apt.14238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Simren M, Palsson OS, Whitehead WE. Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice. Curr Gastroenterol Rep. 2017;19:15. [PMID: 28374308 DOI: 10.1007/s11894-017-0554-0] [Cited by in Crossref: 136] [Cited by in F6Publishing: 103] [Article Influence: 22.7] [Reference Citation Analysis]
|
| 40 |
Shin JE. Understanding the Rome IV: Functional Constipation and Anorectal Disorders. Korean J Med 2017;92:372-381. [DOI: 10.3904/kjm.2017.92.4.372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 41 |
Sirri L, Grandi S, Tossani E. Smoking in Irritable Bowel Syndrome: A Systematic Review. J Dual Diagn 2017;13:184-200. [PMID: 28609199 DOI: 10.1080/15504263.2017.1322226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 42 |
Choung RS, Richard Locke G 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study. Neurogastroenterol Motil 2017;29. [PMID: 28256048 DOI: 10.1111/nmo.13041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 43 |
Turner J. Establishing a nurse-led pelvic floor and functional bowel service. Br J Nurs 2017;26:640-642. [DOI: 10.12968/bjon.2017.26.11.640] [Reference Citation Analysis]
|
| 44 |
Jung SE, Joo NS, Han KS, Kim KN. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome. J Korean Med Sci 2017;32:948-53. [PMID: 28480652 DOI: 10.3346/jkms.2017.32.6.948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 45 |
Chey WD, Dove LS, Andrae DA, Covington PS. Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies. Aliment Pharmacol Ther 2017;45:1319-28. [PMID: 28326568 DOI: 10.1111/apt.14031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 46 |
Tsigaridas A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, Viazis N, Karamanolis G, Karamanolis DG, Tsangaris GT, Mantzaris GJ, Gazouli M. Proteomics and irritable bowel syndrome. Expert Rev Proteomics 2017;14:461-8. [PMID: 28395553 DOI: 10.1080/14789450.2017.1317600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 47 |
Park SY, Khemani D, Nelson AD, Eckert D, Camilleri M. Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation. Clin Gastroenterol Hepatol 2017;15:543-552.e4. [PMID: 27856363 DOI: 10.1016/j.cgh.2016.11.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 48 |
Irvine AJ, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC. Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia. Scand J Gastroenterol 2017;52:396-402. [PMID: 27973922 DOI: 10.1080/00365521.2016.1267792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 49 |
MacQueen G, Surette M, Moayyedi P. The gut microbiota and psychiatric illness. J Psychiatry Neurosci 2017;42:75-7. [PMID: 28245172 DOI: 10.1503/jpn.170028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 50 |
Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR. Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Aliment Pharmacol Ther 2017;45:824-32. [PMID: 28105700 DOI: 10.1111/apt.13949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 51 |
Ghoshal UC, Singh R. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population. J Gastroenterol Hepatol 2017;32:378-87. [PMID: 27262283 DOI: 10.1111/jgh.13465] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 52 |
Canavan C, West J, Card T. Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment. Pharmacoeconomics 2016;34:181-94. [PMID: 26497004 DOI: 10.1007/s40273-015-0339-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 53 |
Simpkins SJ, Pinto-Sanchez MI, Moayyedi P, Bercik P, Morgan DG, Bolino C, Ford AC. Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care. Aliment Pharmacol Ther 2017;45:91-9. [PMID: 27807884 DOI: 10.1111/apt.13846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 54 |
Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease. Clin Endosc 2017;50:578-84. [PMID: 28008163 DOI: 10.5946/ce.2016.129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 55 |
Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut 2016;65:1951-9. [PMID: 26347530 DOI: 10.1136/gutjnl-2015-309889] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 56 |
Sood R, Ford AC. Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same? Nat Rev Gastroenterol Hepatol 2016;13:501-2. [PMID: 27407043 DOI: 10.1038/nrgastro.2016.110] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 57 |
Chumpitazi BP, Weidler EM, Lu DY, Tsai CM, Shulman RJ. Self-Perceived Food Intolerances Are Common and Associated with Clinical Severity in Childhood Irritable Bowel Syndrome. J Acad Nutr Diet. 2016;116:1458-1464. [PMID: 27316779 DOI: 10.1016/j.jand.2016.04.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 58 |
Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 521] [Cited by in F6Publishing: 528] [Article Influence: 74.4] [Reference Citation Analysis]
|
| 59 |
Newberry C, Tierney A, Pickett-Blakely O. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender. Biomed Res Int 2016;2016:1064029. [PMID: 27073800 DOI: 10.1155/2016/1064029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Thijssen AY, Mujagic Z, Jonkers DM, Ludidi S, Keszthelyi D, Hesselink MA, Clemens CH, Conchillo JM, Kruimel JW, Masclee AA. Alterations in serotonin metabolism in the irritable bowel syndrome. Aliment Pharmacol Ther 2016;43:272-82. [PMID: 26538292 DOI: 10.1111/apt.13459] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 61 |
Jarrett ME, Cain KC, Barney PG, Burr RL, Naliboff BD, Shulman R, Zia J, Heitkemper MM. Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016;22:102-111. [PMID: 26459461 DOI: 10.5056/jnm15067] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 62 |
Bielefeldt K, Levinthal DJ, Nusrat S. Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis. J Neurogastroenterol Motil 2016;22:31-45. [PMID: 26717930 DOI: 10.5056/jnm15171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 63 |
Staller K, Barshop K, Kuo B, Ananthakrishnan AN. Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis. Neurogastroenterol Motil 2015;27:1378-88. [PMID: 26172284 DOI: 10.1111/nmo.12628] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 64 |
Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015;114:1638-1646. [PMID: 26382580 DOI: 10.1017/s0007114515003347] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 65 |
Gracie DJ, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, Ford AC. No increase in prevalence of somatization in functional vs organic dyspepsia: a cross-sectional survey. Neurogastroenterol Motil 2015;27:1024-31. [PMID: 25931163 DOI: 10.1111/nmo.12578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, Ford AC. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol 2015;50:816-23. [PMID: 25636675 DOI: 10.3109/00365521.2015.1007079] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 67 |
Pinto-Sanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D, Moayyedi P, Bercik P. Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. Am J Gastroenterol 2015;110:1038-48. [PMID: 25964226 DOI: 10.1038/ajg.2015.128] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 68 |
Littlehales EG, Ford AC. Lubiprostone Is Effective in Treating Functional Bowel Disease With Constipation. Clin Gastroenterol Hepatol 2015;13:1378-9. [PMID: 25290533 DOI: 10.1016/j.cgh.2014.09.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 69 |
Bae S, Lee KJ, Kim YS, Kim KN. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects. J Korean Med Sci 2015;30:757-62. [PMID: 26028929 DOI: 10.3346/jkms.2015.30.6.757] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 70 |
Ford AC, Moayyedi P, Bercik P, Morgan DG, Bolino C, Pintos-sanchez MI, Reinisch W. Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care. American Journal of Gastroenterology 2015;110:716-724. [DOI: 10.1038/ajg.2015.117] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 71 |
Patel P, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P, Ford AC. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Aliment Pharmacol Ther 2015;41:449-58. [PMID: 25586008 DOI: 10.1111/apt.13074] [Cited by in Crossref: 53] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 72 |
Kane JS, Bryan H, Ford AC. Reducing the need for random colonic biopsies in patients with diarrhea. Am J Gastroenterol 2015;110:351-2. [PMID: 25646917 DOI: 10.1038/ajg.2014.401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 73 |
Pierce AN, Christianson JA. Stress and Chronic Pelvic Pain. Molecular and Cell Biology of Pain. Elsevier; 2015. pp. 509-35. [DOI: 10.1016/bs.pmbts.2014.11.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 74 |
Chang L, Lembo AJ, Lavins BJ, Shiff SJ, Hao X, Chickering JG, Jia XD, Currie MG, Kurtz CB, Johnston JM. The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther 2014;40:1302-12. [PMID: 25312449 DOI: 10.1111/apt.12985] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 75 |
Lin S, Mooney PD, Kurien M, Aziz I, Leeds JS, Sanders DS. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. Eur J Gastroenterol Hepatol 2014;26:1176-80. [PMID: 25076066 DOI: 10.1097/MEG.0000000000000171] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 76 |
Macaigne G, Lahmek P, Locher C, Lesgourgues B, Costes L, Nicolas MP, Courillon-Mallet A, Ghilain JM, Bellaïche G, de Montigny-Lehnardt S, Barjonet G, Vitte RL, Faroux R, Lambare B, Fleury A, Pariente A, Nahon S. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol 2014;109:1461-70. [PMID: 25001258 DOI: 10.1038/ajg.2014.182] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 77 |
Appleby RN, Walters JR. The role of bile acids in functional GI disorders. Neurogastroenterol Motil 2014;26:1057-69. [PMID: 24898156 DOI: 10.1111/nmo.12370] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 78 |
Barbara G, Cremon C, Stanghellini V. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences. Curr Opin Gastroenterol 2014;30:352-8. [PMID: 24811054 DOI: 10.1097/MOG.0000000000000070] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 79 |
Lacy BE, Hussain ZH, Mearin F. Treatment for constipation: new and old pharmacological strategies. Neurogastroenterol Motil 2014;26:749-63. [PMID: 24860968 DOI: 10.1111/nmo.12335] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 80 |
De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014;5:419-29. [PMID: 24921926 DOI: 10.4161/gmic.29417] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 10.6] [Reference Citation Analysis]
|
